Evidence map›Paper›PMID 28364943›Full record

Trial reportBiological psychiatry2017

Amygdala Lesions Reduce Anxiety-like Behavior in a Human Benzodiazepine-Sensitive Approach-Avoidance Conflict Test.

Christoph W Korn, Johanna Vunder, Júlia Miró, Lluís Fuentemilla, Rene Hurlemann, Dominik R Bach

Open access · hybridAbstract readRandomized Controlled TrialTwin Study
In one paragraph

Trial report in Biological psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Dissecting the Function of Hippocampal Oscillations in a Human Anxiety Model.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Trial
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Measuring maladaptive avoidance: from animal models to clinical anxiety.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Christoph W KornDivision of Clinical Psychiatry Research, Psychiatric Hospital, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland. Electronic address: christoph.korn@uzh.ch.
Johanna VunderDivision of Clinical Psychiatry Research, Psychiatric Hospital, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland.
Júlia MiróEpilepsy Unit, University Hospital of Bellvitge, Barcelona, Spain.
Lluís FuentemillaCognition and Brain Plasticity Unit, Institute of Biomedicine Research of Bellvitge, Barcelona, Spain; Department of Cognition, Development, and Educational Psychology, Barcelona, Spain; Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Rene HurlemannDepartment of Psychiatry and Division of Medical Psychology, University of Bonn, Bonn, Germany.
Dominik R BachDivision of Clinical Psychiatry Research, Psychiatric Hospital, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland; Wellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom.
University of Zurich · CHBellvitge University Hospital · ESInstitut d'Investigació Biomédica de Bellvitge · ESUniversity of Bonn · DEWellcome Centre for Human Neuroimaging · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRodent approach-avoidance conflict tests are common preclinical models of human anxiety disorder. Their translational validity mainly rests on the observation that anxiolytic drugs reduce rodent anxiety-like behavior. Here, we capitalized on a recently developed approach-avoidance conflict computer game to investigate the impact of benzodiazepines and of amygdala lesions on putative human anxiety-like behavior. In successive epochs of this game, participants collect monetary tokens on a spatial grid while under threat of virtual predation.

methodsIn a preregistered, randomized, double-blind, placebo-controlled trial, we tested the effect of a single dose (1 mg) of lorazepam (n = 59). We then compared 2 patients with bilateral amygdala lesions due to Urbach-Wiethe syndrome with age- and gender-matched control participants (n = 17). Based on a previous report, the primary outcome measure was the effect of intra-epoch time (i.e., an adaptation to increasing potential loss) on presence in the safe quadrant of the spatial grid. We hypothesized reduced loss adaptation in this measure under lorazepam and in patients with amygdala lesions.

resultsLorazepam and amygdala lesions reduced loss adaptation in the primary outcome measure. We found similar results in several secondary outcome measures. The relative reduction of anxiety-like behavior in patients with amygdala lesions was qualitatively and quantitatively indistinguishable from an impact of anterior hippocampus lesions found in a previous report.

conclusionsOur results establish the translational validity of human approach-avoidance conflict tests in terms of anxiolytic drug action. We identified the amygdala, in addition to the hippocampus, as a critical structure in human anxiety-like behavior.

Indexed as

AdultAmygdalaAnti-Anxiety AgentsAnxietyAvoidance LearningBrain InjuriesCase-Control StudiesDouble-Blind MethodFemaleHumansLorazepamMaleTreatment OutcomeYoung AdultAnti-Anxiety AgentsLorazepamAnxiety disorderDouble-blindHippocampusLorazepamPlacebo-controlledUrbach-Wiethe syndrome

Identifiers

PMID28364943
PMCPMC5598543
OpenAlexW2586974476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.